NCT01216631View on ClinicalTrials.gov

Seronegative Oligoarthritis of the Knee Study (SOKS)

PHASE2TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Spondylarthropathies
Interventions
DRUG

methylprednisolone

intra-articular injection of methylprednisolone (80mg given at baseline only)

DRUG

Infliximab

intra-articular injection of 100mg infliximab given at baseline only

DRUG

Infliximab

intravenous infliximab at a dose of 5mg/kg (as per patient weight) given at week 0, 2, 6 and 14

Trial Locations (1)

LS7 4SA

Leeds Teaching Hospitals NHS Trust, Leeds

Sponsors

Collaborators (1)

Centocor, Inc.
All Listed Sponsors
collaborator

Centocor, Inc.

INDUSTRY

lead

University of Leeds

OTHER